Due to the overlap phenomena between ET and PD, investigations into the relationship between PD risk variants and ET patients have been done, involving LINGO1, LINGO2, LRRK2, SLC1A2, and HTRA2 genes [3, 10–12]. This evidence concerns the gene LRRK2 and essential thrombocythemia.